@article{8a008eb4f0cc436a9f40c228cb02649c,
title = "Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C",
abstract = "About 170 million patients worldwide have chronic hepatitis C. Pegylated interferon plus ribavirin is currently the recommended therapy.",
keywords = "Antiviral Agents, Cost-Benefit Analysis, Drug Therapy, Combination, Female, Hepatitis C, Chronic, Humans, Interferons, Male, Randomized Controlled Trials as Topic, Ribavirin, Treatment Outcome",
author = "M Simin and J Brok and D Stimac and C Gluud and Gluud, {L L}",
year = "2007",
month = may,
day = "15",
doi = "10.1111/j.1365-2036.2007.03294.x",
language = "English",
volume = "25",
pages = "1153--62",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "John Wiley and Sons Inc.",
number = "10",
}